- Home
- SIEB vs INO Comparison
SIEB vs INO Comparison
Compare SIEB & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- INO
- Stock Information
- Founded
- SIEB 1886
- INO 1979
- Country
- SIEB United States
- INO United States
- Employees
- SIEB N/A
- INO N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- INO Medical/Dental Instruments
- Sector
- SIEB Finance
- INO Health Care
- Exchange
- SIEB Nasdaq
- INO Nasdaq
- Market Cap
- SIEB 94.9M
- INO 110.7M
- IPO Year
- SIEB N/A
- INO 1998
- Fundamental
- Price
- SIEB $2.92
- INO $1.93
- Analyst Decision
- SIEB
- INO Buy
- Analyst Count
- SIEB 0
- INO 6
- Target Price
- SIEB N/A
- INO $16.33
- AVG Volume (30 Days)
- SIEB 49.1K
- INO 1.2M
- Earning Date
- SIEB 11-12-2024
- INO 11-14-2024
- Dividend Yield
- SIEB N/A
- INO N/A
- EPS Growth
- SIEB 61.43
- INO N/A
- EPS
- SIEB 0.27
- INO N/A
- Revenue
- SIEB $83,357,000.00
- INO $203,413.00
- Revenue This Year
- SIEB N/A
- INO N/A
- Revenue Next Year
- SIEB N/A
- INO $2,290.97
- P/E Ratio
- SIEB $11.37
- INO N/A
- Revenue Growth
- SIEB 27.81
- INO N/A
- 52 Week Low
- SIEB $1.41
- INO $1.91
- 52 Week High
- SIEB $3.31
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- SIEB 50.58
- INO 12.71
- Support Level
- SIEB $3.04
- INO $1.91
- Resistance Level
- SIEB $3.25
- INO $4.08
- Average True Range (ATR)
- SIEB 0.18
- INO 0.25
- MACD
- SIEB -0.03
- INO -0.20
- Stochastic Oscillator
- SIEB 13.04
- INO 1.41
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.